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1. SUMMARY OF PROGRESS 
 
Introduction and Context: 
 
This report details an evaluation of the implementation of treatment summaries for cancer 
patients across the Wessex Deanery, encompassing Hampshire, Dorset and the Isle of 
Wight. The service evaluation commenced at the end of September 2015 and this report 
presents the progress made towards the implementation of cancer treatment summaries 
(CT) across the Wessex Deanery and service users’ experiences of receiving the TSs from 
two NHS Trusts in the catchment area. The survey results present the progress that has 
been made in the first six months of implementation and include descriptive data relating to 
the progress and process of implementation. The qualitative findings from an analysis of 
service user experience are presented and the findings from the evaluation are discussed in 
the context of national policy and the wider literature.  
 
Remit of the Project: 
A mixed method approach has been utilised, following the Logic Model for Evaluation (HM 
Treasury, 2011). The purpose of this evaluation is to monitor the progress and process of 
the implementation of treatment summaries (TS) as part of a key work stream identified by 
the WCSCN (2014).  
The project aims are: 
1. To identify the progress that has been made towards the implementation of treatment 
summaries between April 2015 and September 2015 in acute trusts in the Wessex 
Deanery. 
2. To identify factors that have influenced the process and progress of the 
implementation of treatment summaries in the above Trusts. 
3. To evaluate the experiences of service users who have received care from acute 
Trusts in Wessex Deanery between April 2015 and September 2016. 
 
Method: 
 Stage 1 of the project included a survey of lead cancer nurses in the chosen localities 
to determine the progress made towards the implementation of treatment summaries.  
 Stage 2 involved the use of interviews and focus groups to describe cancer survivors’ 
experiences of receiving a treatment summary. Ethical approval for the evaluation 
has been obtained from Bournemouth University and the project met the criteria for 
service evaluation in IRAS.  
 
Key Findings 
Questionnaire: 
1. Between April and September 2015 three of the participating Trusts had provided 
treatment summaries for patients with colorectal and breast cancer. Of those an 
average of 49% of colorectal patients and 62% of breast cancer patients received a 
treatment summary. 
 
2. Qualitative comments from four of the participating Trusts indicated that from the 
spring of 2016 treatment summaries were being introduced for patients with prostate, 
head and neck, brain and skin cancers. 
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3. A number of challenges were identified by staff involved in implementing TS and 
these included: limited staffing resources, lack of availability and accessibility of IT 
systems, lack of clarity over patient selection and documentation, lack of clarity over 
staff engagement and expectation of roles. 
 
4. Driving forces identified included the recognition of leaders with vision who engaged 
with staff, multidisciplinary involvement and collaboration, education and updates, 
positive feedback and perceived benefits identified by patients and colleagues.  
 
Service user evaluation: 
1. Not all participants could remember receiving a treatment summary and when they 
were given close to completion of the treatment episode some service users 
appeared overwhelmed by the volume of information they had received while others 
were able to select out key information and this appeared to be related to whether or 
not they had previous experience of receiving cancer services. 
 
2. Service users who remembered having a TS had a clear understanding of its 
purpose and thought they were a useful source of key information that could be 
shared with their family and other professionals although for some the technical 
terminology appeared confusing. 
 
3. Service users experienced a good integration of care between the members of the 
cancer team in secondary care. However from their perspectives, they saw no 
integration between primary and secondary care and had not anticipated that there 
would be in the majority of cares.  Those with co-morbidities did however question if 
there should be stronger communication links between the patient, primary and 
secondary care services. 
 
4. The quality of care received from the cancer service teams was consistently praised 
and service users recognised the collaborative effort made. 
 
5. The TS does appear to provide a focus point for sharing information between service 
users and their significant others and appeared to support service users in the self-
management of their survivorship. 
 
Conclusion and recommendations 
This service evaluation has been conducted at a very early stage of service implementation 
and as such the findings can only represent a snapshot of the early transition phase. For the 
participating Trusts, treatment summaries are becoming an integral part of the care for 
cancer survivors with evidence that feedback from GPs and service users is positive. 
Service users’ experiences of receiving treatment summaries has been positive however 
some participants couldn’t remember receiving one, when this happened is was associated 
with  receiving large amounts of information at a time when it was difficult to absorb what 
was happening. Service users also recognised that their care and support came from 
secondary care rather than primary care following completion of a treatment episode. 
Key drivers and lessons learnt from this early evaluation can be used to guide future 
development and these have been presented as recommendations for further development. 
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In summary key recommendations at this stage include the following: 
1. For clinical staff to continue to identify where ambiguities in operational definitions of 
treatment episodes, treatment summaries and patient selection exist and agree a 
way forward. 
 
2. To review the coding and usability of electronic data systems and digital 
communication. 
 
3. To identify examples of good practice in relation to leadership and engagement and 
share this information with others. 
 
4. To engage clinical staff in the provision of education and updates 
 
5. To continue to monitor feedback from service users including patients and primary 
care staff. 
 
6. To support continuing multidisciplinary engagement in secondary care and more 
engagement with primary care. 
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2. INTRODUCTION AND CONTEXT 
 
 
Introduction: 
 
This report details an evaluation of the implementation of treatment summaries for cancer 
patients across the Wessex Deanery, encompassing Hampshire, Dorset and the Isle of 
Wight. The service evaluation commenced at the end of September 2015 and this report 
presents the progress made towards the implementation of cancer treatment summaries 
(CT) across the Wessex Deanery and service users’ experiences of receiving the TSs from 
two NHS Trusts in the catchment area. The survey results present the progress that has 
been made in the first six months of implementation and include descriptive data relating to 
the progress and process of implementation. The qualitative findings from an analysis of 
service user experience are presented and the findings from the evaluation are discussed in 
the context of national policy and the wider literature. Recommendations are made and 
summarised at the end of the discussion section.  
 
The purpose of this report is to present a summary of the key findings from the evaluation, 
highlighting the challenges met during treatment summary implementation as well as the 
progress made. Recommendations are made to support future development and evaluation. 
 
National and policy context:  
A projection of the number of people living in England with cancer in 2012 is 1.8 million and 
by 2030 this figure is estimated to be over 3 million (Independent Cancer Task Force, 2015; 
Macmillan Cancer Support, 2012). There is evidence however that many people who survive 
cancer struggle with the consequences and side effects of treatment and often have unmet 
needs that could have been either avoided or managed more effectively (Treanor et al, 
2013; Santin et al, 2012; Armes et al, 2009).  In 2013 the UK National Cancer Survivorship 
Initiative (DH, Macmillan Cancer Support & NHS Improvement) set out updated actions and 
guidance to improve the outcomes of this client group. One such intervention included the 
implementation of treatment summaries that could be used as part of an integrated package 
of care for cancer survivors. The use of treatment summaries continues to be supported and 
the Independent Cancer Task Force (2015) has recommended that the treatment summary 
should be an integral part of a specified cancer recovery package for every person with 
cancer in England by 2020. 
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Treatment Summaries as a key work stream for the Wessex Cancer Strategic 
Clinical Network (WCSCN): 
Treatment summaries are a key component of survivorship and provide information in an 
accessible format to support early recognition of cancer consequences by patients and 
primary care workers enabling early intervention (Wessex Cancer Strategic Clinical Network, 
WCSCN, 2014). The WCSCN go on to recommend the use of treatment summaries as a 
core part of the communication process between the providers of secondary care, the 
patient and primary care providers. The use of treatment summaries is seen as an important 
step forward towards improving information and continuity of care for cancer survivors.  
 
When treatment summaries were piloted by the National Cancer Survivorship Initiative 
(2010) nationally across eleven test communities in 2009 they were received positively both 
in primary and secondary care. This finding was reinforced locally by findings from focus 
groups of cancer survivors where they valued the importance of having detailed, bespoke 
information that they could share with their GP about their individual treatment and on-going 
cancer care (Airey and Moxham, 2015). 
 
The adoption of treatment summaries as part of standard care in England is still in the early 
stages of implementation and, based on the findings of the National Cancer Patient 
Experience Survey (NCPES), continues to be identified as an area for further development 
and improvement by Quality Health (2014). The findings revealed that when service users 
were asked if they had received a written assessment and care plan as part of their care, 
only 22% of patients reported that they did (Quality Health, 2014). This was in contrast to 
89% of respondents who said that their overall care was excellent or very good. These 
national findings were consistent and comparable with the findings for the acute NHS 
hospital Trusts in the Wessex Deanery area (Quality Health, 2014) and more widely by 
findings in the USA (Klemanski et al, 2016; Hewitt et al, 2005).  
 
In response to the findings produced by Quality Health in 2014, the implementation of 
treatment summaries, as part of the National Cancer Survivorship Initiative Recovery 
Package (2014), was agreed as a key work stream for the WCSCN work programme 
(WCSCN, 2014). This project is part of the Department of Health (DH) domain 3 work stream 
which is focussed on, ‘Helping people to recover from episodes of ill health or following 
injury’ (DH, 2010).  
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Definition of Treatment Summary: 
For the purpose of this report, a treatment summary can be described as a tool to improve 
communication between cancer services, the patient and primary care (Smith and 
Thompson, 2013). The Treatment Summary will be provided by healthcare professionals 
working in secondary care and differs from a standard discharge summary in that it is much 
broader in its remit and should contain the information listed in Table 1 (Macmillan, 2014; 
National Cancer Survivorship Initiative (NCSI) (2010).  
 
Table 1: Information provided as part of a Cancer Treatment Summary (Macmillan, 2014; 
NCSI, 2010) 
Information provided as part of a Cancer Treatment Summary 
 
Date of diagnosis 
Diagnosis 
 
Staging information 
 
Treatment aim 
 
Summary of treatment and relevant dates 
 
Possible treatment toxicities and/or late effects 
 
Alert symptoms that require referral back to a specialist team. 
 
Secondary care on-going management plan 
 
Required GP actions in addition to the cancer care review. 
 
Summary of information given to the patient about their cancer and future 
progress 
 
Additional information including issues relating to lifestyle and support needs 
 
Useful contact numbers 
 
Other service referrals made 
 
DS 1500 application completed (a form to apply for specific benefits if 
terminally ill) 
 
Prescription charge exemption arranged. 
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Treatment summaries and Local Clinical Commissioning Groups: 
Treatment summaries have been included in seven out of nine local Clinical Commissioning 
Groups’ (CCGs) commissioning intentions for 2014-2015, following guidance from the 
WCSCN (2014) that all cancer patients should receive at least one treatment summary. In 
addition work has been undertaken to ensure treatment summaries are included in CCG 
contracts for 2015-2016 either as a quality incentive scheme (CQUIN), as part of a service 
development and improvement plan. The CCGs (2014) who have shown an intention to 
include in contracts for 2015-2016 are: 
 Dorset  
 Fareham and Gosport  
 Isle of Wight  
 North Hampshire  
 North East Hampshire and Farnham  
 Portsmouth  
 South East Hampshire  
 Southampton  
 West Hampshire  
 
The acute NHS Trusts in the Wessex Deanery that are included in this contract are: 
 Dorset County Hospital NHS Foundation Trust 
 Hampshire Hospitals NHS Foundation Trust 
 Isle of Wight NHS Trust 
 Poole Hospital NHS Foundation Trust 
 Portsmouth Hospitals NHS Trust 
 Royal Bournemouth and Christchurch Hospitals NHS  Foundation Trust 
 University Hospital Southampton NHS Foundation Trust 
 
This report focuses on the progress made towards the implementation of treatment 
summaries in the Wessex Deanery as part of their quality improvement plan and includes 
data collected from September 2015 to October 2016. 
 
3. EVALUATION METHOD 
A mixed method approach has been utilised, following the Logic Model for Evaluation (HM 
Treasury, 2011). The purpose of this evaluation is to monitor the progress and process of 
the implementation of treatment summaries as part of a key work stream identified by the 
WCSCN (2014). The date of policy implementation was April 2015 and the timing of data 
collection within the first 6 months of implementation is consistent with the use of a process 
evaluation that describes and measures initial challenges and driving forces that influence 
the progress of implementation (HM Treasury, 2011).  
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Aims: 
The project aims are: 
1. To identify the progress that has been made towards the implementation of treatment 
summaries between April 2015 and September 2015 in acute trusts in the Wessex 
Deanery. 
2. To identify factors that have influenced the process and progress of the 
implementation of treatment summaries in the above Trusts. 
3. To evaluate the experiences of service users who have received care from acute 
Trusts in Wessex Deanery between April and September 2016. 
 
Scope and Design: 
The evaluation includes a two stage mixed method approach.  
 
Stage 1: includes a survey of lead cancer nurses in the chosen localities to determine the 
progress made towards the implementation of treatment summaries and relates to project 
aims 1 and 2.  
 
Stage 2:   Service users from a variety of sites have been invited to take part in focus groups 
at locations that are convenient to them. The focus groups will consist of a minimum of 4 
participants up to a maximum of 10. The option of face to face or telephone interviews will be 
available for cancer survivors who wish to take part but who are unable to attend on the date 
specified. 
 
Ethical approval and Trust permissions: 
This project has been considered by IRAS to be service evaluation and does not require 
ethical approval under the NHS Research Governance Framework. The evaluation is 
however subject to local Trust information governance approval. Permission to access the 
sample sites are being obtained through the Trusts’ Information Governance/ Audit teams 
and the lead cancer nurses in each Trust. To date 6 of the 7 acute Trusts have given 
permission for stage 1 of the study to take place and two Trusts have given permission for 
stage 2 to commence.  Because the project involves undertaking interviews and focus 
groups with vulnerable groups the research team sought ethical approval through 
Bournemouth University and this was obtained in September 2015. 
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Sampling Strategies: 
 
Stage 1: The lead cancer nurses from the 7 acute trusts contracted to implement treatment 
summaries have been selected by the WCSCN as the people best placed to complete the 
survey based on their strategic knowledge of cancer care in the their trust.  
 
Stage 2: The Trusts included in a case-study approach will be selected according to the  
following criteria: 
 The Trust will be part of the sample group included in the Wessex Deanery 
population. 
 Cancer survivors will have received treatment in that locality during the evaluation 
period 
 
Participants for the focus groups and interviews will be selected using purposive sampling 
with the guidance of lead nurses working in the case-study Trusts. A participant information 
sheet and consent form will be provided in advance of data collection to allow a cooling off 
period.  
 
Access to Trusts and permission to collect data: 
 Permission to access Lead Cancer Nurses in each Acute Care Trust was agreed and 
supported by Wessex Strategic Clinical Networks in July 2015 and this provided an 
opportunity to pilot the survey for stage 1. 
 
 Permission to access the Trusts in order to collect data has taken longer and after 
obtaining ethical approval in September 2015, permission to access 6 of the 7 trusts 
has been granted. The findings represent data obtained from the six participating 
trusts. 
 
Pilot study and testing of the survey tool: 
A pilot questionnaire was developed based on the requirements of the funders and available 
literature (WCSCN, 2015; Rechis et al, 2014; Jabson and Bowen, 2014). The questionnaire 
was tested with the lead cancer nurses in two Trusts in the Wessex Deanery during July 
2015. Of the Trusts who agreed to take part in the pilot study, one was based in a rural area 
(Trust A) and one in an urban setting (Trust B). Data were collected during a face to face 
interview using the pilot questionnaire as a guide. 
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The data from the pilot survey revealed that, at the time of collecting the data Trust A and 
Trust B were at different stages of progression towards the implementation of treatment 
summaries: 
 Trust A described their progress as going through a staged implementation plan that 
facilitated gradual increase in the number of cancer diagnostic related groups being 
included as the project expanded. Trust B described being at a very early stage of 
implementation and were not able to identify which diagnostic related groups were 
included in the implementation plan at that stage. 
 At this early stage factors that appeared to affect the progress of implementation 
related to: 
o staff attitudes and motivation  
o stakeholder involvement in the change process 
o funding and support 
 There also appeared to be inconsistency in:  
o The definition of a treatment episode 
o when a treatment summary should be provided  
o who provides the treatment summary 
 There was an indication that data on the number of patients who have received 
treatment summaries may not be available in all Trusts due to proposed changes in 
the way the clinical coding data is stored and the transition from paper based data to 
an electronic data base. 
Based on the findings of the pilot survey the following amendments to the questionnaire 
have been made: 
 Three questions have been added to the questionnaire including: 
o How do you define the term “treatment episode” in your Trust? 
o Are there any factors that have inhibited the progress of treatment summary 
implementation? 
o Are there any factors that have driven the use of treatment summaries 
forward? 
 Each question in the survey is followed by a request to include further information if 
relevant. 
A full version of the questionnaire is available in Appendix A. 
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4. FINDINGS  
4.1 Survey Results: 
The provision of treatment summaries between April and September 2015  
The bar chart below provides a summary of the percentage of cancer patients who received 
a treatment summary based on the data available for the period between April and 
September 2015. Of the six Trusts included in the study, three Trusts were able to provide 
data for this period, two of the trusts provided numerical data while the third presented their 
data as percentages.  
 
 
 
In Trust A the number of patients with colorectal cancer who completed a treatment episode 
between April and August 2015 was 54 and of those 23 (42%) received a treatment 
summary. For patients with breast cancer, 81 patients completed a treatment episode with 
29 (35%) receiving a treatment summary.  
In Trust E, 180 patients with colorectal cancer completed a treatment episode with 100 
(55%) receiving treatment summaries. Also 300 patients with breast cancer completed a 
treatment episode with 100% of patients receiving  a consultation record (treatment 
summary) after each episode of treatment including post-surgery, post radiotherapy and post 
chemotherapy (Please see Table 2). 
A third, Trust D provided an estimated percentage of the number of colorectal patients who 
had received a TS as 55%, with less than 50% of breast cancer patients receiving a TS. 
0.0
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Bar chart: The percentage of cancer patients who completed a 
treatment episode and received a treatment summary in the 
participating Trusts 
Colorectal Breast
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The remaining groups did not know or did not specify numbers but did offer qualitative 
comments to explain this. 
 In Trust A, no data relating to treatment episodes for prostate and other cancers 
were available for the time period April- August but from February 2016 patients with 
prostate cancer completing a treatment episode will receive a treatment summary.  
 In Trust D electronic treatment summaries were introduced at the end of 2015 for 
patients receiving treatment for breast, head and neck, colorectal, brain and skin 
cancers. In April 2016 patients receiving treatment for lung and prostate cancers will 
also receive treatment summaries. 
 Trust E did not specify a plan for rolling out treatment summaries to other specialities 
but they did note that some specialities such as haematology already use treatment 
summaries for some patients as part of their care pathway.   
 In Trust F the respondent recognised that TS are not yet available as part of the 
patient’s electronic care record and that this had made collation of figures difficult. 
This is being recognised and addressed at a regional level. 
 Other qualitative comments in this section related to the following: 
o Patients receiving palliative care will not be provided with a TS 
o TS are more likely to be used where follow-up care is nurse led  
o The template for the TS provided is not always clinically appropriate for the 
patient’s care. 
These findings are summarised in table 2. 
 
Definition of a treatment episode and provision of treatment summaries: 
At the time of data collection there appeared to be some differences of opinion around what 
denotes a treatment episode and how this relates to patients receiving a treatment summary. 
For example: 
Treatment summary is completed by the team in each of the specialities and  
will be given to the patient at the end of the treatment package. Some patients  
in colorectal speciality will receive a treatment summary at the end of each stage.  
(Trust A) 
Reference is made to the term “treatment package” as being different to a “stage” of 
treatment. This statement was further qualified when reference was made to some 
individuals who receive a treatment summary at the end of a “package” of treatment that 
included several treatment episodes, rather than at the end of each “stage” of specialist 
treatment. It was also recognised that some patients may receive combination treatment and 
that where this occurs it is defined as one treatment episode. Trust A for example, referred 
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to patients with colorectal cancer who receive one treatment summary at the end of the 
treatment package when the person’s care is transferred to primary care.  They also 
identified that treatment summaries for some people receiving complex care were 
individually tailored to the person’s treatment journey.  
In Trust D the timing of TS provision is related to the cancer type. However as a general rule 
the TS is provided at the end of a treatment episode at the first follow-up appointment. This 
could be between 6 weeks and 6 months post treatment. 
In Trust E a treatment episode was defined as being aligned to an episode of specialist care 
along a patient’s cancer experience: 
Whilst this has never been articulated I think that most would define the term  
treatment episode as an episode of care along an individual patient’s cancer  
experience which requires expert clinical care. (Trust E) 
 
The example used to illustrate this referred to an individual receiving treatment for breast 
cancer that may have three episodes of treatment including: surgery, radiotherapy and 
chemotherapy. This interpretation was reinforced by staff in Trust D where colleagues 
interpreted an episode of treatment as a single modality of treatment such as hormone 
treatment, surgery or adjunctive treatment- each one being a treatment episode. One 
respondent defined a treatment episode as a “treatment pathway” explaining that a TS would 
be given at the end of the surgical pathway, for example. They described treatment 
summaries being individually tailored to the patient care pathway with completed summaries 
being provided at different times along the pathway. 
 
The findings therefore suggest that each Trust and /or area of cancer speciality has defined 
a treatment episode to be consistent with the package of care provided and that decisions 
are made about when a TS is provided according to cancer type, interventions provided and 
the patient’s progress.  
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Table 2: The number (n) and percentage of cancer patients who completed a treatment 
episode and received a treatment summary in the participating Trusts 
Trust Cancer  
Type 
Completed 
episode (n) 
Received 
summary (n) 
Received 
summary (%) 
A Colorectal 
54 23 42% 
Breast 81 29 35% 
Prostate 
0 0 0 
C No data available 
 
D  
Colorectal 
 
Not specified Not specified 50% 
Breast Not specified Not specified 
< 50%   
 
Prostate Not specified Not specified 
Not specified 
E  
Colorectal 
 
180 100 55% 
Breast 300 300 100% 
Prostate 125 0 0% 
F  
Colorectal 
 
Not known Not known Not known 
Breast Not known Not known Not known 
Prostate Not known Not known Not known 
G No data available 
 
 
 
People and processes involved in the format and completion of the TS 
 
In Trust A for people experiencing colorectal cancer, the individuals who complete the 
treatment summary are either the consultant or the nurse. For people with breast cancer, 
there is a different system in that a nurse administrator has been employed to complete and 
provide treatment summaries. The treatment summaries are then delivered to the patient in 
person with a letter sent to their address. At the moment the patient’s GP also receives a 
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copy of the letter but work is being undertaken to explore the feasibility of emailing the letters 
to both the patient and GP where appropriate. 
 
In Trust D the TSs are given to the patients by the clinical nurse specialist in each speciality, 
a copy is also placed in the patient’s hospital notes for use by the multidisciplinary team. 
 
In Trust E, for patients with colorectal cancer the treatment summary may be completed by 
either the consultant, specialist registrar or the clinical nurse specialist. For patients with 
breast cancer it may be completed by the consultant or radiotherapist. Patients received 
their treatment summaries in person but no reference is made to how or whether the 
information is sent to the patient’s GP. 
 
In Trust F, again the clinical nurse specialist gives the patient their TS after liaising with the 
medical team. Patients are provided with a paper version and a copy is sent to the GP. 
 
The most frequently used format at the time of data collection was a standard treatment 
summary template. 
 
Factors that have challenged the implementation of treatment summaries:  
Analysis of the qualitative date collected from the survey revealed that the staff had 
experienced a number of challenges to implementation across the Trusts and these included 
the following themes: 
 Resource challenges 
 Availability and accessibility of information technology (IT) systems 
 Lack of clarity over patient selection and documentation 
 Role expectations and staff engagement 
Table three summarises the themes supported by quotes from the respondents. 
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Table 3: Challenges encountered when implementing treatment summaries 
Theme Quotes from respondents 
Resource challenges 
 
 Limited staff time and pressure of workload (Trust A) 
 Staffing shortages, especially qualified nurses, nurse staffing 
vacancies in the specialities (Trust A) 
 Time (Trust E) 
 Asking more of the CNS without providing an increase in 
resources (Trust F) 
 There are increasing numbers of patients being diagnosed 
with cancer (Trust F) 
Availability and 
accessibility of IT 
systems 
 
 IT (Trust E) 
 The interface between the IT systems of primary and 
secondary care (Trust F) 
 The difficulty associated with extracting data on TS from the 
electronic data base (Trust F) 
 We work around our IT systems rather than them working for 
us (Trust F) 
Lack of clarity over 
patient selection and 
documentation 
 
 Lack of knowledge and clarity over who treatment summaries 
are aimed at (Trust E) 
 Lack of knowledge and clarity about what contributes a patient 
treatment summary (Trust E) 
 During the targeted time frame there was a lack of a coherent 
system and consistency around regional implementation (Trust 
D) 
 Lack of clarity over what is the correct paperwork (Trust E) 
 I believe there is too much confusion with regards to treatment 
summaries (Trust E) 
Role expectations and 
staff engagement 
 
 An expectation that this is a “nursing” i.e. CNS 
job/role/requirement leading to a lack of medical staff 
engagement (Trust E) 
 Unrealistic expectations (Trust F) 
 Implementation basically down to the CNS (Trust F) 
 
 
 
Factors that have driven forward the use of cancer treatment summaries and ideas for 
future development 
Analysis of the qualitative date collected from the survey revealed that the staff had 
recognised some factors that had driven forward the implementation of treatment summaries 
and that where they been implemented there had been perceived benefits. Some 
respondents also identified ideas that could be considered when planning the future 
development of the service. All together six themes were identified and they include:  
 Targets 
 Leaders with vision who engage all staff 
 Education and updates 
 Multidisciplinary involvement and collaboration 
 Positive feedback and perceived benefits 
 IT systems 
Table four summarises the themes supported by quotes from the respondents. 
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Table 4: Factors that have been perceived to have driven forward the implementation of 
cancer treatment summaries and ideas for future development 
Theme Quotes from respondents 
Targets  Awareness and need to comply with CQUINN target (Trust A) 
 The need for national targets (Trust F) 
 
Leaders with vision 
who engage all staff 
 Individuals within the organisation who see their value and worth 
and attempt to share the vision and a lead who has the time to 
drive the initiative forward (Trust E) 
 Leadership by lead nurses, doctors and cancer service 
management team (Trust A) 
 
Education and updates  Our cancer services manager was promoted and delivered a 
focused awareness campaign to staff about the initiative (Trust A) 
 The CNS to have input into the education of district nurses for 
undertaking cancer reviews (Trust D) 
 Combined education sessions between primary and secondary 
care (Trust D) 
 
Multidisciplinary 
involvement and 
collaboration 
 An increase in clinicians’ involvement (Trust D) 
 Multi-clinical involvement (Trust D) 
 Greater collaboration between the participating Trusts across 
Dorset (Trust D) 
 
Positive feedback and 
perceived benefits 
 Staff motivated and enthusiastic and can see the value in this 
initiative, benefits to patients and the wider MDT such as GPs 
(Trust A) 
 Better care and communication for patients (Trust A) 
 GPs in the locality have provided positive feedback on the initiative 
(Trust A) 
 Patients have fed back positively on the benefits of receiving the 
TS (Trust A) 
 The clinical team see the benefit and value of TS from the patient 
perspective and this increases commitment (Trust F) 
 
IT systems   There is a need to improve IT systems linking primary and 
secondary care (Trust D) 
 To be able to email GP surgeries (Trust D) 
 The development of an electronic treatment summary that links 
with other systems (Trust D) 
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4.2: Findings from service user experience data 
 
Two Trusts agreed to take part in the service user evaluation of treatment summaries, trusts 
A and D. Data were collected using one focus group of four people and two face to face 
interviews. Service users were selected and contacted by the lead cancer nurses on the 
basis that they had all received a treatment summary following an episode of treatment. 
Service users who took part in the study included people with colorectal cancer, breast 
cancer and head and neck cancer. Some family members were invited to take part in the 
study in situations where the service user felt more comfortable with them present. A further 
three service users who agreed to take part in the study were unable to attend and declined 
to be interviewed by telephone. Analysis of the data revealed five themes developed from 11 
categories and these are included in the table five. 
 
Table 5: Themes and categories related to service user experience of cancer treatment 
summaries  
Themes Categories 
1. Timing and delivery 
of treatment 
summaries 
 Knowing or not knowing if I have had a treatment summary 
 When the treatment summary was received measured by 
days of treatment completion, weeks or months after the 
treatment episode 
 How the TS was delivered- by post or by hand 
2. Purpose of the 
treatment summary 
 Alerts to side effects and symptoms 
 Who is the treatment summary for the patient or the 
professional? 
3. Integration of care  Integration of information between primary and secondary 
care 
 Focus on providing support from secondary care as the first 
point of call 
4. Quality of care  Feeling fortunate 
 High quality care 
5. Family centred care  Sharing with the family 
 Being a team 
 
In the theme: timing and delivery of treatment summaries some service users couldn’t 
remember receiving a treatment summary even when a sample template was shown to 
them. For example one service user from Trust D described: 
I didn’t receive anything like that, at least I don’t remember …  
I only finished my treatment a few weeks ago 
 
Another service user from Trust D had a different story:  
 Oh I’ve had loads of leaflets … sheets of paper telling me what  
will happen… 
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Both of these participants had treatment for head and neck cancer and had completed a 
treatment episode at approximately the same time however, neither felt that receiving the 
treatment summary was significant at the time.  One service user in Trust D had received a 
treatment summary following a treatment episode for breast cancer and was very clear 
about when she received it and by whom: 
The treatment summary came when I was discharged from hospital…  
I was discharged with it. 
 
A service user in Trust A who had received treatment for colorectal cancer also clearly 
remembered receiving his treatment summary and went on to explain that he wasn’t 
expecting it at all: 
It would be useful to be informed when you’re discharged that you’ll get a TS.  
The timing and delivery of the TS also varied considerably among the service users with one 
participant receiving his 6 months after his treatment episode, while others were either 
posted or talked through and given out by specialist nurses at the point of discharge. This 
finding is consistent with the survey data. Service users who received their TS between two 
to six months after their treatment episode described how their “mind was more capable of 
taking things in”. One service user said: 
… there were two cancer nurses trying to talk me through things but it  
wouldn’t stay in, trying to all absorb that, what I needed was a tape recorder! 
 
For some service users, their latest treatment episode was following a reoccurrence of their 
cancer and they appeared to be more receptive to the information given, saying that they 
had a better idea of what to expect. From this evaluation it appears that not all participants 
could remember receiving a treatment summary and when they were given close to 
completion of the treatment episode, some service users appeared overwhelmed by the 
volume of information they received while others were able to select out key information and 
this appeared to be related to whether or not they had previous experience of receiving 
cancer treatment. 
 
In theme two: purpose of the treatment summary those service users who acknowledged 
receipt of their treatment summary were able to describe what they thought it was for and 
stressed that it was to alert them to the symptoms and side effects of their cancer and the 
treatment they had received. They also stressed the importance of knowing who to call if 
they were concerned or needed advice. In Trust A the service user stated: 
The information is very clear about the procedure, but I already knew  
that because the surgeon had told me… it reinforced what I already knew. 
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Some service users felt the treatment summary was more for the professionals than for 
them: 
There’s a lot about the cancer itself and its growth rate some people  
may not appreciate what that means. What’s a DS1500 application?  
I don’t know what that means? 
 
You should have two forms, one for the patient and one for the professional. 
 
One service user who had comorbidities raised the question about whether treatment 
summaries may be useful for other patient groups living with chronic conditions so that 
people could have a better understanding of what was happening and where to go for help.    
All service users agreed that the information available from a treatment summary could be 
and was used to share information with their families.  
 
Overall service users who remembered having a TS had a clear understanding of the 
purpose of a treatment summary and thought they were a useful source of key information 
that could be shared with their family and other professionals although for some, the 
technical terminology appeared confusing. 
 
In theme three: integration of care all service users and family members interviewed 
shared the view that the treatment summary was related to the relationship they had with the 
cancer specialist team (secondary care). None of the service users who participated in the 
study had engaged with their GP following their treatment episode and were not fully aware 
of what the GP had been told. Some service users noted that they were not give a discharge 
letter to take to their GP so had no need to attend the surgery. In Trust A one service user 
who completed his treatment six months before had not had any contact with his GP: 
The hospital has been fine but I’ve not had anything from my GP at all. 
 
In Trust D three service users knew what the ongoing treatment plan from the hospital was 
but had not considered going to see their GP: 
It’s all to do with the hospital, I see my GP once a year for blood tests  
because it’s the only way I can get them done. I don’t even go to the  
surgery for my repeat prescriptions. 
 
Service users described feeling safe and secure because they could contact the specialist 
team if they had any problems rather than go to their GP.  
 
In summary the findings demonstrated good integration of care between the service user 
and the cancer team in secondary care. However from the service users’ perspectives they 
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saw no integration between primary and secondary care and had not anticipated that there 
would be in the majority of cases.  Those with co-morbidities did however question if there 
should be stronger communication links between the patient, primary and secondary care 
services. 
 
In theme four: quality of care all the service users praised the quality of care they had 
received and the accessibility of staff in the specialist cancer units. Some service users saw 
themselves as being: 
… in a privileged position because we do receive a lot of information and  
the system works. 
 
In summary the quality of care received from the cancer service teams was consistently 
praised and service users recognised the collaborative effort made.  
 
In theme five: family centred care all service users recognised the importance of family in 
their treatment and recovery. One service user identified that he and his wife were a team: 
We have coped with it quite well haven’t we….? It was a joint thing,  
we did it together. 
 
One service user who received radiotherapy explained: 
They let me keep the mask, all the family wanted to see it,  
especially the grandchildren. 
 
Another service user described: 
When my hair started to grow back my grandson came over to me and  
stroked my head and said- Ooh it’s just like the cat’s fur. …  
it makes it easier when you can talk about it with the family. 
 
All service users described sharing all the information they had received, including the 
treatment summary, with their family “my wife reads everything!”  Interestingly there was 
considerable family interest when service users were invited to participate in the evaluation 
and this led to some family members being part of the evaluation process. 
 
In summary one significant feature of the TS was that it appeared to provide a focus point for 
sharing information between service users and their significant others and appeared to 
support service users in the self-management of their survivorship. 
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5. DISCUSSION 
 
The first aim of this evaluation was to determine the progress made towards the 
implementation of treatment summaries received by patients between April and August 2015 
across the Wessex Deanery. In this evaluation ambiguity around the definition of a treatment 
episode has impacted on the ability to compare findings across Trusts. This was further 
complicated by the use of the term “treatment package” which relates to the whole package 
of care provided at the point where care is transferred from secondary to primary care. 
According to Smith and Thompson (2013) a treatment episode relates an acute treatment 
phase, with a treatment summary provided at the end of each phase. This should also be an 
integral part of the holistic needs assessment and care planning and the cancer care review 
in primary care. The relationship between the definition of a treatment episode and the 
provision of a treatment summary does seem to be an area for future discussion and 
clarification for the accuracy and benefit of future audits.  
 
Recommendation 1: 
For clinical staff to continue to identify where ambiguities in operational definitions of 
treatment episodes, treatment summaries and patient selection exist and agree a way 
forward. 
 
In relation to progress made towards implementation, the findings suggest that patients who 
fall into the colorectal and breast cancer groups were in receipt of treatment summaries 
although not all patients experiencing a treatment episode received a treatment summary. 
The percentage varied according to Trusts but overall uptake for colorectal cancer patients 
across the Trusts included was 49 %. For breast cancer the overall uptake was higher at 
58%. This finding must be viewed with caution however because of the ambiguity of 
interpretation between definitions of a treatment episode.  
 
Recommendation 2: 
To review the coding and usability of electronic data systems and digital 
communication. 
 
These results can be considered to be very positive when compared with findings from 
international studies on the implementation of treatment summaries. For example in USA the 
average uptake is between 31-38% with colorectal and breast cancer specialities as early 
adopters (Jabson, 2015; Rechis et al, 2014; Jabson and Bowen, 2013; Sabatino et al, 2013). 
This comparison should be considered with caution however due to the different definitions 
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of treatment summaries used and the timing of the evaluation which occurred 4-5 years after 
the publication of national USA guidelines, compared to 1-2 years in the UK.  Nevertheless 
in spite of endorsements from key stakeholders, the uptake of treatment summaries in the 
USA for cancer survivors in the last 10 years is less than 50% (Klemanski et al, 2016; 
Rechis et al, 2014; Jabson and Bowen, 2014).  
 
The second aim of this survey was to identify factors that have influenced the process of 
implementation. The challenges identified in the findings can be summarised as: resource 
challenges including: time, staff skill mix and documentation; role expectation and staff 
engagement; availability and accessibility of information technology (IT) systems; and lack of 
clarity over patient selection and documentation. These findings are similar to findings 
identified in the literature. For example in a systematic review of care plan preferences of 
cancer survivors and health care providers by Klemanski et al (2016), they identified that 
issues and barriers to implementation of care plans and treatment summaries included: 
debates about who should complete them, the time and cost involved, lack of consensus 
over format and concerns about sustainability of provision. Klemanski et al (2016) concluded 
that the provision of treatment summaries and care plans is strongly based on the principle 
of beneficence rather than rigorous evidence and that more work is required in order to 
explore the relationship between treatment summaries, care plans and patient outcomes.  
 
Recommendation 3: 
To identify examples of good practice in relation to leadership and engagement and 
share this information with others. 
 
In relation to service user experience, the UK, outcome data on the benefits of treatment 
summaries for cancer patients has yet to be demonstrated due to the early stage of 
implementation across the UK nations. The qualitative findings from this evaluation however 
do highlight that positive feedback from service users and GPs in primary care on the 
benefits of treatment summaries acts as a motivator for clinical staff to continue their 
commitment and enthusiasm for the continued implementation of TS. Similarly 
multidisciplinary involvement and collaboration was seen as a positive factor in the 
implementation of treatment summaries, along with visionary leadership, education and 
updates; and IT systems that are fit for purpose. These findings are similar to studies that 
have identified factors that positively influenced the implementation of service improvement 
and clinical guidelines in health care settings (Jun et al, 2016; Rajasekhar et al, 2016; Ebben 
et al, 2015; van de Steeg et al, 2014; McCluskey et al, 2013; Abrahamson et al, 2012).  
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These have included: positive feedback from service users and perceived improvements in 
the quality of care have improved the motivation and engagement of clinical staff involved; 
leadership and engagement; education and updates and effective management of 
resources.  
 
Recommendation 4: 
To engage clinical staff in the provision of education and updates. 
 
In this service user evaluation however several participants could not remember having a 
treatment summary, saying that they felt overwhelmed with information at a stressful time. 
Those who have previous experience of having cancer and those who had their TS several 
months later appeared to see the benefits of the TS. The timing of delivery for the treatment 
summary, up to six months after completion of the treatment episode, highlights what Brown 
et al (2016, p196) describe as an “important teachable moment at the end of treatment”  In 
their study of 19 colorectal cancer survivors in the UK, they found that participants who had 
received information at the end of a treatment episode benefited from increased information 
provision about treatment consequences at a later stage and this supported increased 
patient empowerment and self-management. Brown et al’s (2016) study also highlights the 
uniqueness of cancer survivor’s experiences and while one survivor is willing to engage with 
the support systems available this may not be reflected in a wider population of survivors 
with different needs. In this evaluation some of the service users preferred to seek support in 
the family rather than through cancer support groups, while others actively engaged in all the 
support and activities that were offered. 
For the participants in this study the treatment summary provided a reminder of the 
information received as part of the discharge planning process and provided a resource for 
sharing information with their families. This finding is consistent with findings from a study by 
Blanch-Hartigan et al (2015) who found that in a study of 359 cancer survivors , where 
34.5% had received treatment summaries, there was a positive correlation between the 
receipt of a treatment summary and improved patient centred communication and perceived 
quality of care. However in this evaluation all service users had received a treatment 
summary and all described receiving high quality care although there appeared to be no 
direct link between the two factors. 
 
Recommendation 5: 
To continue to monitor feedback from service users about their experiences of 
receiving treatment summaries. 
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The question of what should be in a treatment summary and to whom it should be directed 
was raised by participants in stage one of the evaluation and continued to be issue for the 
service users in stage two. According to Smith and Thompson (2013) the TS was designed 
to improve communication between cancer services and primary care, however for some 
service users the technical information included in the TS did not always make sense.  
 
Recommendation 6: 
To support continuing multidisciplinary engagement in secondary care and more 
engagement with primary care. 
 
The National Cancer Survival Initiative in 2013 proposed that a greater collaboration 
between primary and secondary care can provide a risk stratified approach to supporting 
cancer survivors through the short and long term consequences of cancer treatment. In this 
evaluation the findings suggest that from the service users’ perspective there is still a divide 
between specialist support and support available via GPs in primary care. Service users are 
still contacting specialist services when they can rather than communicating with their GP. 
According to Walter et al (2015) following an online survey of GPs in England they found that 
GPs have a potentially important role in caring for people following cancer treatment and that 
timely use of cancer treatment summaries could enhance communication between 
secondary care providers, primary care and cancer survivors. However I this evaluation 
service users preferred to contact the cancer services rather than their GP. 
 
 
6. CONCLUSION AND RECOMMENDATIONS 
 
This service evaluation has been conducted at a very early stage of service implementation 
and as such the findings can only represent a snapshot of the early transition phase. For the 
participating Trusts, treatment summaries are becoming an integral part of the care for 
cancer survivors with evidence that feedback from GPs and service users is positive. 
Service users’ experiences of receiving treatment summaries has been positive however 
some participants couldn’t remember receiving one, when this happened is was associated 
with  receiving large amounts of information at a time when it was difficult to absorb what 
was happening. Service users also recognised that their care and support came from 
secondary care rather than primary care following completion of a treatment episode. 
Key drivers and lessons learnt from this early evaluation can be used to guide future 
development and these have been presented as recommendations for further development. 
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In summary key recommendations at this stage include the following: 
7. For clinical staff to continue to identify where ambiguities in operational definitions of 
treatment episodes, treatment summaries and patient selection exist and agree a 
way forward. 
 
8. To review the coding and usability of electronic data systems and digital 
communication. 
 
9. To identify examples of good practice in relation to leadership and engagement and 
share this information with others. 
 
10. To engage clinical staff in the provision of education and updates 
 
11. To continue to monitor feedback from service users including patients and primary 
care staff. 
 
12. To support continuing multidisciplinary engagement in secondary care and more 
engagement with primary care. 
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